176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-11.66%
Both yoy net incomes decline, with MRVL at -26.69%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-3.57%
Negative yoy D&A while MRVL is 1.70%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-100.69%
Negative yoy deferred tax while MRVL stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-25.75%
Negative yoy SBC while MRVL is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
115.01%
Slight usage while MRVL is negative at -60.05%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
79.44%
AR growth of 79.44% while MRVL is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-102.10%
Both reduce yoy inventory, with MRVL at -9.49%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
158.78%
AP growth of 158.78% while MRVL is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
97.33%
Some yoy usage while MRVL is negative at -118.56%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-100.18%
Both negative yoy, with MRVL at -100.00%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
6579.03%
Some CFO growth while MRVL is negative at -30.65%. John Neff would note a short-term liquidity lead over the competitor.
-50.53%
Negative yoy CapEx while MRVL is 89.33%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
100.00%
Acquisition spending well above MRVL's 100.00%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
-58.50%
Both yoy lines negative, with MRVL at -123.53%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-12.28%
We reduce yoy sales while MRVL is 42.31%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-100.00%
We reduce yoy other investing while MRVL is 91.81%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-344.73%
We reduce yoy invests while MRVL stands at 68.30%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
89.64%
Stock issuance far above MRVL's 29.53%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
No Data
No Data available this quarter, please select a different quarter.